GlobalGov › Switzerland › Award

INSTITUT DE FORMULATION DES VACCINS (CH) SA won ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES from National Institutes of Health

National Institutes of Health · Switzerland government award

GlobalGov surfaces government contract awards from around the world, including the markets your competitors overlook.

$6.9M
Award Value
April 24, 2026
Award Date
Awarded
Status

Award Overview

INSTITUT DE FORMULATION DES VACCINS (CH) SA was awarded ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES by National Institutes of Health in Switzerland, tracked by GlobalGov. The award is valued at $6.9M. It was awarded on April 24, 2026. Classification: NAICS 541512, PSC AN12. Full award details and the issuing agency are below.

See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.

Start Free

Award Details

AwardeeINSTITUT DE FORMULATION DES VACCINS (CH) SA
Awardee countrySwitzerland
Awarding agencyNational Institutes of Health
CountrySwitzerland
Award value$6.9M
Award dateApril 24, 2026
NAICS541512
PSCAN12
Place of performanceSwitzerland
Last verifiedSeptember 1, 2026

Source: U.S. Government (USAspending.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

Switzerland market overview →Browse open opportunities →

Track every Switzerland contract award and the opportunities behind them. Free for 14 days.

Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required